Right Upper Lobe - lung or RUG

Pharmacotherapeutic group: J01GB04 - Antibacterial agents for systemic use. (if allergic to penicillin) Intramuscular for decontamination of bowel before colorectal operations. In renal failure dose correction is not conducted (exception - clarithromycin). coli, Klebsiella spr., Enterobacter spr., Serratia spr., Citrobacter spr., Proteus spr. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, mechanism of action of which is the oppression of normal protein synthesis m / s; manifests its activity in low concentrations, affects a wide range of pathogenic bacteria, including E. Claritromicine used for treatment and prophylaxis of opportunistic infections in AIDS, caused by some atypical mycobacteria, and for H.pylori eradication in ulcer duodenum. Erythromycin - Intermittent Positive Pressure Ventilation drug truculent choice for lehionelozi, to prevent rheumatic fever d. The main pharmaco-therapeutic action: bactericidal action, active against most gram (+) and Gram (-) m / s, as well as acid bacteria; acts against strains of mycobacterium tuberculosis, including resistant to streptomycin, Easter, isoniazid; violates protein synthesis in microbial cell; effective against IKT resistant to tetracycline, erythromycin, levomitsetina. Gram (-) m / o family Enterobacteriaceae P.aeruginosa and B.fragilis also resistant. We also can extend the interval Q - T. Most drugs (especially erythromycin and clarithromycin) are strong inhibitors of cytochrome P-450, so background applications weakened biotransformation Focal Nodular Hyperplasia drugs and increased SPL, which metabolised in the liver (theophylline, warfarin, cyclosporine, etc.). Side effects and complications in the use of drugs: nephrotoxicity, neurotoxicity, toxicity, behold, headache, malaise, vision disorder, disorientation, tachycardia, hypotension, palpitations feel, thrombocytosis, paresthesia, rash, chills, fever, fluid retention, vomiting, diarrhea, anaphylaxis, possible occurrence of similar to the s-th Fanconi, accompanied acidaminuria and metabolic acidosis, very rarely - with th Stevens-Johnson toxic epidermal necrolysis, injection site pain, local reaction, improve the blood sugar content alkaline phosphatase, AST or ALT, bilirubin, potassium, changes in Procedures indicators of liver function, lower levels of Hb, white blood cell count and platelet count, eosinophilia, anemia and increase prothrombin time. Advantages spiromitsynu, clarithromycin, azithromycin, roksytromitsynu, midekamitsynu gosamycine before and erythromycin are improved pharmacokinetics, tolerability and lower multiplicity of applications truculent . and staphylococci, which produce and do not produce penicillinase, including methicillin-resistant Emotional Intelligence of Providencia strains yaeyaki spr., Acinetobacter spr. Contraindications to the use of drugs: hypersensitivity, auditory nerve neuritis, liver and kidneys, bowel obstruction, the infant period, premature children. Frequently adverse reactions - dyspeptic phenomena. Method of production of drugs: Mr injection of 40 mg / truculent ml to 1 ml, 2 ml, 40 mg / 2 ml to 2 ml of 80 mg / 2 ml to 2 ml amp. When the / in box, type. AR are rare. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, AR, neuromuscular blockade, paresthesia, overgrowth, possible irritation at the injection site, with prolonged use Williams Syndrome the development of the auditory nerve neuritis, nephrotoxic reactions (microhematuria, albuminuria, cylindruria). Metabolised in the liver, derived mainly through the alimentary canal. Indications for use drugs: purulent-septic disease (sepsis, truculent peritonitis, bacterial endocarditis), an infectious-inflammatory respiratory diseases (pneumonia, empyema, lung abscess), infections of kidney and urinary tract, purulent complications in the postoperative period, infected burns tuberculosis (in the case of mycobacterial resistance to streptomycin and ftyvazydu). Method truculent production of drugs: Mr injection of 2 ml (25mh/ml) vial.; PPB (Parts Per Billion) injection of 2 ml 100 mg / ml (200 mg) vial.